MedinCell S.A. (EPA:MEDCL)

France · Delayed Price · Currency is EUR

28.16

+0.10 (0.36%)

At close: Nov 28, 2025

Revenue by Product

Financials in millions EUR. Fiscal year is April - March.

Millions EUR. Fiscal year is Apr - Mar.

Year Ending	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	2014 - 2018
Long-acting Injectable Drugs	9.03M	Log In	Log In	Log In	Log In	Upgrade
Long-acting Injectable Drugs Growth	-8.67%	Log In	Log In	Log In	Log In	Upgrade
Licenses, Milestones	-	Log In	Log In	Log In	Log In	Upgrade
Licenses, Milestones Growth	-	Log In	Log In	Log In	Log In	Upgrade
Products Received under Development Benefit	-	Log In	Log In	Log In	Log In	Upgrade
Products Received under Development Benefit Growth	-	Log In	Log In	Log In	Log In	Upgrade
Royalties	-	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions EUR. Fiscal year is April - March.

Millions EUR. Fiscal year is Apr - Mar.

Year Ending	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	2014 - 2018
France	9.03M	Log In	Log In	Log In	Log In	Upgrade
France Growth	-8.67%	Log In	Log In	Log In	Log In	Upgrade